Article info

Download PDFPDF

Research paper
Early use of donepezil against psychosis and cognitive decline in Parkinson’s disease: a randomised controlled trial for 2 years

Authors

  1. Correspondence to Dr Hideyuki Sawada, Clinical Research Center and Department of Neurology, Utano National Hospital, Kyoto 6168255, Japan; sawada.unh{at}gmail.com
View Full Text

Citation

Sawada H, Oeda T, Kohsaka M, et al
Early use of donepezil against psychosis and cognitive decline in Parkinson’s disease: a randomised controlled trial for 2 years

Publication history

  • Received January 28, 2018
  • Revised April 27, 2018
  • Accepted July 10, 2018
  • First published August 3, 2018.
Online issue publication 
November 21, 2018

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.